Gemmer Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-125
Closed -$3K 1342
2021
Q3
$3K Hold
125
﹤0.01% 1160
2021
Q2
$4K Hold
125
﹤0.01% 1234
2021
Q1
$3K Sell
125
-100
-44% -$2.51K ﹤0.01% 1321
2020
Q4
$4K Buy
+225
New +$2.78K ﹤0.01% 1140

Other funds holding RNLX

Gemmer Asset Management's RNLX Position: Q4 2021 in Review

Gemmer Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2021, closing a stake of 125 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in RNLX in Q4 2020 and held it in 4 quarters. The position peaked at $4K in Q2 2021. 33 funds tracked by Wall St. Rank hold RNLX as of Q4 2021.

  • Gemmer Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Gemmer Asset Management sold 125 Renalytix plc American Depositary Shares shares in Q4 2021, an estimated $3K.
  • Gemmer Asset Management first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 4 quarters.
  • Gemmer Asset Management's Renalytix plc American Depositary Shares position peaked at $4K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2021.

Based on Gemmer Asset Management's 13F filing for Q4 2021, filed 21 Jan 2022.